Drug Profile
Research programme: immunological disorders therapy - Shionogi
Alternative Names: S-2678Latest Information Update: 20 Aug 2010
Price :
$50
*
At a glance
- Originator Shionogi
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Transplant rejection
Most Recent Events
- 25 Oct 2005 Preclinical trials in Cancer in Japan (unspecified route)
- 25 Oct 2005 Preclinical trials in Transplant rejection in Japan (unspecified route)